M. Rothman

发表

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

J. Farrar, N. Bellamy, B. Galer, 2003, Pain.

Can we use social media to support content validity of patient-reported outcome instruments in medical product development?

P. Wicks, E. Papadopoulos, M. Rothman, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.

David Cella, Charles S Cleeland, Alejandro R Jadad, 2008, The journal of pain : official journal of the American Pain Society.

Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report.

Pennifer Erickson, Laurie Burke, N. Leidy, 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine

D. Patrick, S. Bull, M. Rothman, 2008, BJU international.

Patient-reported Outcomes for Multicentric Castleman’s Disease in a Randomized, Placebo-controlled Study of Siltuximab

N. Munshi, A. Dispenzieri, A. Fosså, 2015, The Patient - Patient-Centered Outcomes Research.

Performance of two self-report measures for evaluating obesity and weight loss.

D. Patrick, D. Bushnell, M. Rothman, 2004, Obesity research.

Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations

Richard E. White, J. Heyse, J. Chandler, 2008, PAIN.

Using the patient global assessment of the method of pain control to assess new analgesic modalities in clinical trials*

D. Hewitt, M. Rothman, C. Damaraju, 2009, Current medical research and opinion.

Determining Clinically Important Differences in Health Status Measures

G. Samsa, D. Matchar, G. R. Williams, 1999, PharmacoEconomics.

Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial.

J. Rossi, N. Munshi, H. van de Velde, 2014, The Lancet. Oncology.

Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials.

W. Stewart, J. Zeldis, M. Rothman, 2001, Digestive diseases and sciences.

Characterizing the burden of premature ejaculation from a patient and partner perspective: a multi-country qualitative analysis

D. Revicki, M. Rothman, J. Hanlon, 2008, Health and quality of life outcomes.

Premature ejaculation: results from a five-country European observational study.

D. Patrick, A. Kokoszka, F. Giuliano, 2008, European urology.

Premature ejaculation: an observational study of men and their partners.

D. Patrick, R. Rosen, M. Rothman, 2005, The journal of sexual medicine.

Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials.

C. McMahon, M. Rothman, S. Levine, 2011, The journal of sexual medicine.

Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001.

N. Leidy, C. Acquadro, D. Revicki, 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Validity of the patient-reported Clinical Global Impression of Change as a measure of treatment response in men with premature ejaculation.

S. Bull, R. Rosen, M. Rothman, 2010, The journal of sexual medicine.

Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries.

F. Giuliano, M. Rothman, D. Rivas, 2009, European urology.

Patient-reported outcomes: conceptual issues.

J. Cappelleri, J. Lipscomb, M. Rothman, 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The infant gastroesophageal reflux questionnaire revised: development and validation as an evaluative instrument.

D. Revicki, L. Kleinman, S. Cucchiara, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial.

E. Basch, H. Scher, C. Sternberg, 2012, The Lancet. Oncology.

Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy.

H. Scher, C. Cleeland, J. Bono, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations

Richard E. White, J. Farrar, R. Gershon, 2006, Pain.

Effect of abiraterone acetate (AA) on pain control and skeletal-related events (SRE) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) post docetaxel (D): Results from the COU-AA-301 phase III study.

E. Basch, H. Scher, J. Bono, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic non-malignant pain

M. Rothman, James A. D. Otis, 2006, Current medical research and opinion.

The psychological burden of premature ejaculation.

D. Patrick, M. Rothman, D. Rowland, 2007, The Journal of urology.

The Premature Ejaculation Profile: validation of self‐reported outcome measures for research and practice

F. Giuliano, M. Rothman, K. Ho, 2009, BJU international.

Interrelationships among measures of premature ejaculation: the central role of perceived control.

D. Patrick, M. Rothman, D. Rowland, 2007, The journal of sexual medicine.

Addendum to: “Dapoxetine for the Treatment of Premature Ejaculation: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial in 22 Countries” [Eur Urol 2009;55:957–68]

F. Giuliano, M. Rothman, D. Rivas, 2009 .

ORIGINAL RESEARCH—EJACULATORY DISORDERS Treatment of Premature Ejaculation in the Asia-Pacific Region: Results from a Phase III Double-blind, Parallel-group Study of Dapoxetine

C. McMahon, M. Rothman, N. Park, 2010 .

Use of a self-report constipation questionnaire with older adults in long-term care.

L. Frank, J. Flynn, M. Rothman, 2001, The Gerontologist.

Time and economic cost of constipation care in nursing homes.

J. Schmier, J. Schnelle, L. Kleinman, 2002, Journal of the American Medical Directors Association.

Comments on "Considerations for an evidence-based definition of premature ejaculation in the DSM-V".

P. Jern, W. Hellstrom, A. Bella, 2010, The journal of sexual medicine.

Statement nterpreting the Clinical Importance of Treatment Outcomes n Chronic Pain Clinical Trials : IMMPACT Recommendations

K. Schmader, J. Chandler, J. Farrar, 2008 .

Outcomes Assessment in Cancer: Invited Paper D Industry perspective regarding outcomes research in oncology

N. Santanello, R. Willke, J. Gagnon, 2004 .

Symptoms Associated with Gastroesophageal Reflux Disease

W. Stewart, J. Zeldis, M. Rothman, 2001, Digestive Diseases and Sciences.

Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia

D. Patrick, P. Morosini, D. Wild, 2009 .

D. Revicki, B. Luce, M. Rothman, 1992, PharmacoEconomics.

Validation of a Bowel Function Diary for Assessing Opioid-Induced Constipation

M. Camilleri, M. Rothman, K. Ho, 2011, The American Journal of Gastroenterology.

PATIENT REPORTED OUTCOMES AND IMPROVEMENTS IN INTRAVAGINAL EJACULATORY LATENCY TIME IN DAPOXETINE-TREATED MEN WITH LIFELONG OR ACQUIRED PREMATURE EJACULATION: PHASE 3 POOLED ANALYSES

I. Sharlip, C. McMahon, M. Rothman, 2009 .

PREMATURE EJACULATION: RESULTS FROM A EUROPEAN OBSERVATIONAL STUDY

D. Patrick, F. Giuliano, M. Rothman, 2006 .

LACK OF WITHDRAWAL SYNDROME OR EFFECTS ON ANXIETY WITH DAPOXETINE (DPX) FOR THE TREATMENT OF PREMATURE EJACULATION (PE): RESULTS FROM 2 PHASE III TRIALS

R. Rosen, F. Giuliano, M. Rothman, 2008 .

PATIENT-REPORTED OUTCOMES: THE EXAMPLE OF HEALTH-RELATED QUALITY OF LIFE-A EUROPEAN GUIDANCE DOCUMENT FOR THE IMPROVED INTEGRATION OF ASSESSMENT IN THE DRUG REGULATORY PROCESS HEALTH-RELATED QUALITY OF LIFE

F. Schubert, O. Chassany, N. Aaronson, 2002 .

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy and Safety Of Siltuximab, An Anti-Interleukin-6 Monoclonal Antibody, In Patients With Multicentric Castleman’s Disease

N. Munshi, A. Fosså, S. Chaturvedi, 2013 .

The Multicentric Castleman's Disease (Mcd) -Symptom Scale (Mcd-Ss): Development and Validation of A Patient-Reported Outcome (Pro) Measure for An Ultra-Orphan Disease.

J. Vermeulen, M. Qi, M. Rothman, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

A New Decision Model for Cost-Utility Comparisons of Chemotherapy in Recurrent Metastatic Breast Cancer

J. Hutton, K. Abrams, Ruth E. Brown, 2012, PharmacoEconomics.

The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes.

J. Sloan, A. Dueck, M. Rothman, 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.

D. Patrick, P. Morosini, T. Burns, 2010, Clinical therapeutics.

Independent effect of paliperidone extended release on social functioning beyond its effect on positive and negative symptoms of schizophrenia: a mediation analysis.

P. Lim, I. Nuamah, M. Rothman, 2009, Journal of clinical psychopharmacology.

The ORTHO BC-SAT – a satisfaction questionnaire for women using hormonal contraceptives

D. Patrick, M. Rothman, A. Friedman, 2006, Quality of Life Research.

IMPACT OF PREMATURE EJACULATION (PE) ON FEMALE PARTNERS: RESULTS FROM A 5-COUNTRY EUROPEAN OBSERVATIONAL STUDY

D. Patrick, A. Kokoszka, F. Giuliano, 2008 .

EFFECTS OF DAPOXETINE (DPX) FOR THE TREATMENT OF PREMATURE EJACULATION (PE) ON THE ERECTILE FUNCTION AND SCALES OF MOOD AND AFFECT

M. Rothman, D. Rivas, R. Mudumbi, 2008 .

Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia.

D. Patrick, P. Morosini, D. Wild, 2009, Current medical research and opinion.

Recommendations on health-related quality of life research to support labeling and promotional claims in the United States

I. Barofsky, D. Osoba, N. Leidy, 2004, Quality of Life Research.

A comparison of three health status measures in primary care outpatients

G. Samsa, D. Edelman, M. Rothman, 1999, Journal of General Internal Medicine.

Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial.

J. Rossi, N. Munshi, A. Fosså, 2014, The Lancet. Oncology.

Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials.

C. McMahon, M. Rothman, S. Levine, 2011, The journal of sexual medicine.

ORIGINAL RESEARCH—EJACULATORY DISORDERSORIGINAL RESEARCH—EJACULATORY DISORDERS: Premature Ejaculation: An Observational Study of Men and Their Partners

D. Patrick, R. Rosen, M. Rothman, 2005 .

ORIGINAL RESEARCH—EJACULATORY DISORDERS: Interrelationships Among Measures of Premature Ejaculation: The Central Role of Perceived Control

D. Patrick, M. Rothman, D. Rowland, 2007 .

ORIGINAL RESEARCH—EJACULATORY DISORDERS Treatment of Premature Ejaculation in the Asia-Pacific Region: Results from a Phase III Double-blind, Parallel-group Study of Dapoxetine

C. McMahon, M. Rothman, N. Park, 2010 .

Outcomes Assessment in Cancer: Invited Paper D Industry perspective regarding outcomes research in oncology

N. Santanello, R. Willke, J. Gagnon, 2004 .